previous compound ID: 1371 next compound
InChIKey: MGCCHNLNRBULBU-WZTVWXICSA-N
SMILES: CC1=C(C=CC=C1NC2=C(C=CC=N2)C(=O)O)C(F)(F)F.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "GW Carlile" "J Goepp" "E Matthes" "DY Thomas" "JW Hanrahan" "J Liao" "B Kus" "R Robert" "D Rotin"

chemical graph of compound 1371





CID is 39212
synonyms found at PubChem are:
FLUNIXIN MEGLUMINE, 42461-84-7, Flunixin meglumin, Banamine, finadyne, Flumeglumine, Flunixin-S, Sch 14714 meglumine, Flunixin N-methylglucanine, Flunixin (meglumine), Banamine (Veterinary), UNII-8Y3JK0JW3U, Sch-14714 meglumine, EINECS 255-836-0, 8Y3JK0JW3U, CHEBI:76144, 1-Deoxy-1-(methylamino)-D-glucitol 2-(2-methyl-3-(perfluoromethyl)anilino)nicotinate, 2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid meglumine salt, 2-(alpha(sup 3),alpha(sup 3),alpha(sup 3)-Trifluoro-2,3-xylidino)nicotinic acid compound with 1-deoxy-1-(methylamino)-D-glucitol (1:1), 1-Deoxy-1-(methylamino)-D-glucitol 2-[2-methyl-3-(perfluoromethyl)anilino]nicotinate, 2-((2-Methyl-3-(trifluoromethyl)-phenyl)amino)-3-pyridinecarboxylic acid with meglumine compounded, 3-Pyridinecarboxylic acid, 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)-, compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:1), D-Glucitol, 1-deoxy-1-(methylamino)-, 2-((2-methyl-3-(trifluoromethyl)phenyl)amino)-3-pyridinecarboxylate (salt), SMR000875279, SR-05000001901, Flunixin Meglumine [USAN], Equileve, Ilium Flunixil, Flunixin meglumine [USAN:USP], (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol;2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid, C14H11F3N2O2.C7H17NO5, PubChem15394, Flunixin meglumine (USP), Flunixin N-Methylglucamine, Banamine [vetarynary] (TN), SCHEMBL43691, BSPBio_002558, MLS001333159, MLS002153985, SPECTRUM1505113, AC1L21A7, CHEMBL1733447, CTK8F9789, C21H28F3N3O7, MGCCHNLNRBULBU-WZTVWXICSA-N, MolPort-003-666-584, HMS2093I10, HMS2234K05, Pharmakon1600-01505113, HY-B0386, NIH 10250, NSC759583, s2108, Flunixin meglumine, >=98% (HPLC), AKOS015895954, AC-6012, API0025954, CCG-213338, CS-2460, KS-5126, NSC-759583, KS-000010G2, NCGC00180889-01, 2-((2-methyl-3-(trifluoromethyl)- phenyl)amino)-3-pyridinecarboxylic acid with meglumine compounded, LS-71360, SC-18614, AB2000512, FT-0626443, D04216, K-8817, AB00920714_05, AB00920714_06, 461F847, C-22876, I06-1248, Q-201124, SR-05000001901-1, SR-05000001901-3, Flunixin meglumine, European Pharmacopoeia (EP) Reference Standard, Flunixin meglumine, United States Pharmacopeia (USP) Reference Standard, 2-(2-Methyl-3-trifluoromethylanilino)nicotinic Acid N-Methyl-D-glucamine Salt, Flunixin Meglumine, Pharmaceutical Secondary Standard; Certified Reference Material, (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol 2-(2-methyl-3-(trifluoromethyl)phenylamino)nicotinate, (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol; 2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid, 1-deoxy-1-(methylazaniumyl)-D-glucitol 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}nicotinate, 2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic Acid 1-Deoxy-1-(methylamino)-D-glucitol, 2-{[2-methyl-3-(trifluoromethyl)phenyl]amino}nicotinic acid--1-deoxy-1-(methylamino)-D-glucitol (1/1)